Myeloperoxidase, superoxide dismutase-3, cardiometabolic risk factors, and distal sensorimotor polyneuropathy: The KORA F4/FF4 study.
Christian HerderJulia M KannenbergCornelia HuthMaren Carstensen-KirbergWolfgang RathmannWolfgang KoenigAlexander StromGidon J BönhofMargit HeierBarbara ThorandAnnette PetersMichael RodenChrista MeisingerDan ZieglerPublished in: Diabetes/metabolism research and reviews (2018)
Systemic levels of both pro- and antioxidant enzymes appear involved in cardiometabolic risk and development of DSPN.